The retention of WT p53 in cancer cells can also affect the tumor-stroma interaction, most clearly by supporting the activation of an anti-tumor immune response (Bezzi et al. 2018; Wellenstein et al. 2019; Blagih et al. 2020b). Here, TP53 is linked to cancer.